Empagliflozin attenuates cardiac microvascular ischemia/reperfusion through activating the AMPKα1/ULK1/FUNDC1/mitophagy pathway
Open accessThe DOI matches its Crossref record; 71 of the 71 references it cites were found in a registry or an index.
Abstract
Mitophagy preserves microvascular structure and function during myocardial ischemia/reperfusion (I/R) injury. Empagliflozin, an anti-diabetes drug, may also protect mitochondria. We explored whether empagliflozin could reduce cardiac microvascular I/R injury by enhancing mitophagy. In mice, I/R injury induced luminal stenosis, microvessel wall damage, erythrocyte accumulation and perfusion defects in the myocardial microcirculation. Additionally, I/R triggered endothelial hyperpermeability and myocardial neutrophil infiltration, which upregulated adhesive factors and endothelin-1 but downregulated vascular endothelial cadherin and endothelial nitric oxide synthase in heart tissue. In vitro, I/R impaired the endothelial barrier function and integrity of cardiac microvascular endothelial cells (CMECs), while empagliflozin preserved CMEC homeostasis and thus maintained cardiac microvascular structure and function. I/R activated mitochondrial fission, oxidative stress and apoptotic signaling in CMECs, whereas empagliflozin normalized mitochondrial fission and fusion, neutralized supraphysiologic reactive oxygen species concentrations and suppressed mitochondrial apoptosis. Empagliflozin exerted these protective effects by activating FUNDC1-dependent mitophagy through the AMPKα1/ULK1 pathway. Both in vitro and in vivo, genetic ablation of AMPKα1 or FUNDC1 abolished the beneficial effects of empagliflozin on the myocardial microvasculature and CMECs. Taken together, the preservation of mitochondrial function through an activation of the AMPKα1/ULK1/FUNDC1/mitophagy pathway is the working mechanism of empagliflozin in attenuating cardiac microvascular I/R injury.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Zhou, H., Wang, J., Zhu, P., Zhu, H., Toan, S., Hu, S., Ren, J., & Chen, Y. (2018) · Basic Research in Cardiology · doi:10.1007/s00395-018-0682-1 · Cited by 297
Self-citationRetractedTian, F., & Zhang, Y. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.636553 · Cited by 10
RetractedEmpagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
Zinman, B., Wanner, C., Lachin, J. M., Fitchett, D., Bluhmki, E., Hantel, S., Mattheus, M., Devins, T., Johansen, O. E., Woerle, H. J., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1504720 · Cited by 12,315
AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1
Kim, J., Kundu, M., Viollet, B., & Guan, K.-L. (2011) · Nature Cell Biology · doi:10.1038/ncb2152 · Cited by 7,227 · cited 1×
“Reduced energy production increases AMP levels and thus promotes the phosphorylation of AMPKα1, which directly activates ULK1 by phosphorylating it at Ser317 or Ser777 [73].”
BackgroundMultitarget Strategies to Reduce Myocardial Ischemia/Reperfusion Injury
Davidson, S. M., Ferdinandy, P., Andreadou, I., Bøtker, H. E., Heusch, G., Ibáñez, B., Ovize, M., Schulz, R., Yellon, D. M., Hausenloy, D. J., et al. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.09.086 · Cited by 699
Zhou, H., Wang, S., Zhu, P., Hu, S., Chen, Y., & Ren, J. (2018) · Redox Biology · doi:10.1016/j.redox.2017.12.019 · Cited by 550 · cited 3×
“Regarding mitochondrial biology, empagliflozin was found to inhibit hyperglycemia-induced mitochondrial fission [20] and lipopolysaccharide-stimulated mitochondrial oxidative stress [21] by activating AMP-activated protein kinase catalytic subunit alpha 1 (AMPKα1).”
BackgroundMethodJin, Q., Li, R., Hu, N., Xin, T., Zhu, P., Hu, S., Ma, S., Zhu, H., Ren, J., & Zhou, H. (2018) · Redox Biology · doi:10.1016/j.redox.2017.11.004 · Cited by 463
Self-citationZhou, H., Zhu, P., Wang, J., Zhu, H., Ren, J., & Chen, Y. (2018) · Cell Death & Differentiation · doi:10.1038/s41418-018-0086-7 · Cited by 416
Self-citationHawley, S. A., Ford, R. J., Smith, B. K., Gowans, G. J., Mancini, S. J., Pitt, R. D., Day, E. A., Salt, I. P., Steinberg, G. R., & Hardie, D. G. (2016) · Diabetes · doi:10.2337/db16-0058 · Cited by 391
Zhu, P., Hu, S., Jin, Q., Li, D., Tian, F., Toan, S., Li, Y., Zhou, H., & Chen, Y. (2018) · Redox Biology · doi:10.1016/j.redox.2018.02.019 · Cited by 379
Self-citationZhou, H., Zhang, Y., Hu, S., Shi, C., Zhu, P., Ma, Q., Jin, Q., Cao, F., Tian, F., & Chen, Y. (2017) · Journal of Pineal Research · doi:10.1111/jpi.12413 · Cited by 378
Self-citationKolijn, D., Pabel, S., Tian, Y., Lódi, M., Herwig, M., Carrizzo, A., Zhazykbayeva, S., Kovács, Á., Fülöp, G. Á., Falcão-Pires, I., et al. (2021) · Cardiovascular Research · doi:10.1093/cvr/cvaa123 · Cited by 323
Mitochondrial quality control mechanisms as molecular targets in cardiac ischemia–reperfusion injury
Wang, J., & Zhou, H. (2020) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2020.03.004 · Cited by 323
Self-citationNew insights into the role of mitochondria in cardiac microvascular ischemia/reperfusion injury
Wang, J., Toan, S., & Zhou, H. (2020) · Angiogenesis · doi:10.1007/s10456-020-09720-2 · Cited by 311
Self-citationZhou, H., Hu, S., Jin, Q., Shi, C., Zhang, Y., Zhu, P., Ma, Q., Tian, F., & Chen, Y. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.116.005328 · Cited by 306
Self-citationShao, Q., Meng, L., Lee, S., Tse, G., Gong, M., Zhang, Z., Zhao, J., Zhao, Y., Li, G., & Liu, T. (2019) · Cardiovascular Diabetology · doi:10.1186/s12933-019-0964-4 · Cited by 293
Zhou, H., Li, D., Zhu, P., Hu, S., Hu, N., Ma, S., Zhang, Y., Han, T., Ren, J., Cao, F., et al. (2017) · Journal of Pineal Research · doi:10.1111/jpi.12438 · Cited by 253
Self-citationRole of mitochondrial quality surveillance in myocardial infarction: From bench to bedside
Zhou, H., Ren, J., Toan, S., & Mui, D. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101250 · Cited by 249
Self-citationMancini, S. J., Boyd, D., Katwan, O. J., Strembitska, A., Almabrouk, T. A., Kennedy, S., Palmer, T. M., & Salt, I. P. (2018) · Scientific Reports · doi:10.1038/s41598-018-23420-4 · Cited by 240
Chang, X., Lochner, A., Wang, H.-H., Wang, S., Zhu, H., Ren, J., & Zhou, H. (2021) · Theranostics · doi:10.7150/thno.60143 · Cited by 229
Self-citationWang, J., Zhu, P., Li, R., Ren, J., & Zhou, H. (2020) · Redox Biology · doi:10.1016/j.redox.2019.101415 · Cited by 221
Self-citationMitophagy receptor FUNDC1 regulates mitochondrial homeostasis and protects the heart from I/R injury
Zhang, W., Siraj, S., Zhang, R., & Chen, Q. (2017) · Autophagy · doi:10.1080/15548627.2017.1300224 · Cited by 199
Zhang, Y., Zhou, H., Wu, W., Shi, C., Hu, S., Yin, T., Ma, Q., Han, T., Zhang, Y., Tian, F., et al. (2016) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.03.035 · Cited by 189
Self-citationWang, J., Toan, S., & Zhou, H. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104771 · Cited by 183
Self-citationAMPK/ULK1-mediated phosphorylation of Parkin ACT domain mediates an early step in mitophagy
Hung, C.-M., Lombardo, P. S., Malik, N., Brun, S. N., Hellberg, K., Van Nostrand, J. L., Garcia, D., Baumgart, J., Diffenderfer, K., Asara, J. M., et al. (2021) · Science Advances · doi:10.1126/sciadv.abg4544 · Cited by 171
Zhou, H., Shi, C., Hu, S., Zhu, H., Ren, J., & Chen, Y. (2018) · Angiogenesis · doi:10.1007/s10456-018-9611-z · Cited by 170
Self-citationPark, S., Belcastro, E., Hasan, H., Matsushita, K., Marchandot, B., Abbas, M., Toti, F., Auger, C., Jesel, L., Ohlmann, P., et al. (2021) · Cardiovascular Diabetology · doi:10.1186/s12933-021-01252-3 · Cited by 163
Zhou, H., Wang, J., Zhu, P., Hu, S., & Ren, J. T. (2018) · Cellular Signalling · doi:10.1016/j.cellsig.2018.01.020 · Cited by 153
Self-citationMitochondrial quality surveillance as a therapeutic target in myocardial infarction
Zhu, H., Toan, S., Mui, D., & Zhou, H. (2020) · Acta Physiologica · doi:10.1111/apha.13590 · Cited by 147
Self-citationLee, N., Heo, Y. J., Choi, S.-E., Jeon, J. Y., Han, S. J., Kim, D. J., Kang, Y., Lee, K. W., & Kim, H. J. (2021) · Journal of Immunology Research · doi:10.1155/2021/9944880 · Cited by 139
Wang, J., Zhu, P., Li, R., Ren, J., Zhang, Y., & Zhou, H. (2020) · Theranostics · doi:10.7150/thno.40098 · Cited by 134
Self-citationSu, L., Chen, J., Liu, M., Chen, Y., Wu, Y., Li, Q., Ma, T., Gao, J., Xia, Y., Fan, M., et al. (2021) · Basic Research in Cardiology · doi:10.1007/s00395-021-00905-4 · Cited by 116
Fichman, Y., Myers, R. J., Grant, D. G., & Mittler, R. (2021) · Science Signaling · doi:10.1126/scisignal.abf0322 · Cited by 110
Essential requirement for JPT2 in NAADP-evoked Ca 2+ signaling
Gunaratne, G. S., Brailoiu, E., He, S., Unterwald, E. M., Patel, S., Slama, J. T., Walseth, T. F., & Marchant, J. S. (2021) · Science Signaling · doi:10.1126/scisignal.abd5605 · Cited by 110
Xiao, Y., Chen, W., Zhong, Z.-H., Ding, L., Bai, H., Chen, H., Zhang, H., Gu, Y.-H., & Lu, S.-F. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110148 · Cited by 109
Zhou, H., Wang, J., Hu, S., Zhu, H., Toan, S., & Ren, J. T. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27308 · Cited by 98
Self-citationAbdel-latif, R. G., Rifaai, R. A., & Amin, E. F. (2020) · Archives of Pharmacal Research · doi:10.1007/s12272-020-01237-y · Cited by 92 · cited 1×
“It is well documented that the intracellular effectors of empagliflozin include extracellular signal-regulated kinase 1/2 [65], phosphoinositide 3-kinase/Akt [18], transforming growth factor β1 [66], nuclear factor κB [67], Janus kinase 2 [67], Sirtuin 1 [68], hypoxia inducible factor 1α [69], protein kinase G Iα [70]…”
BackgroundBDNF-mediated mitophagy alleviates high-glucose-induced brain microvascular endothelial cell injury
Jin, H. L., Zhu, Y., Li, Y., Ding, X., Ma, W., Han, X., & Wang, B. (2019) · APOPTOSIS · doi:10.1007/s10495-019-01535-x · Cited by 89
Behnammanesh, G., Durante, G. L., Khanna, Y. P., Peyton, K. J., & Durante, W. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101527 · Cited by 87
Crooks, D. R., Maio, N., Lang, M., Ricketts, C. J., Vocke, C. D., Gurram, S., Turan, S., Kim, Y., Cawthon, G. M., Sohelian, F., et al. (2021) · Science Signaling · doi:10.1126/scisignal.abc4436 · Cited by 87
Li, X., Römer, G., Kerindongo, R. P., Hermanides, J., Albrecht, M., Hollmann, M. W., Zuurbier, C. J., Preckel, B., & Weber, N. C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22116044 · Cited by 83
Pum2-Mff axis fine-tunes mitochondrial quality control in acute ischemic kidney injury
Wang, J., Zhu, P., Toan, S., Li, R., Ren, J. T., & Zhou, H. (2020) · Cell Biology and Toxicology · doi:10.1007/s10565-020-09513-9 · Cited by 80
Self-citationNikolaou, P., Efentakis, P., Qourah, F. A., Femminò, S., Makridakis, M., Kanaki, Z., Varela, A., Tsoumani, M. E., Davos, C. H., Dimitriou, C. A., et al. (2020) · Antioxidants and Redox Signaling · doi:10.1089/ars.2019.7923 · Cited by 80
Mitophagy in depression: Pathophysiology and treatment targets
Tripathi, A., Scaini, G., Barichello, T., Quevedo, J., & Pillai, A. (2021) · Mitochondrion · doi:10.1016/j.mito.2021.08.016 · Cited by 75
Empagliflozin protects the heart against ischemia/reperfusion-induced sudden cardiac death
Hu, Z., Ju, F., Du, L., & Abbott, G. W. (2021) · Cardiovascular Diabetology · doi:10.1186/s12933-021-01392-6 · Cited by 73
Endothelial TLR2 promotes proangiogenic immune cell recruitment and tumor angiogenesis
McCoy, M. G., Nascimento, D. W., Veleeparambil, M., Murtazina, R., Gao, D., Tkachenko, S., Podrez, E. A., & Byzova, T. V. (2021) · Science Signaling · doi:10.1126/scisignal.abc5371 · Cited by 59
Wu, H., Ye, M., Liu, D., Yang, J. M., Ding, J., Zhang, J., Wang, X., Dong, W., Fan, Z., & Yang, J. (2019) · Journal of Cellular Biochemistry · doi:10.1002/jcb.28812 · Cited by 55
Begandt, D., Comstra, H. S., Molina, S. A., Krüger, N., Ruddiman, C. A., Chen, Y., Chen, X., Biwer, L. A., Johnstone, S. R., Lohman, A. W., et al. (2021) · Science Signaling · doi:10.1126/scisignal.aba2940 · Cited by 53
Daud, E., Ertracht, O., Bandel, N., Moady, G., Shehadeh, M., Reuveni, T., & Atar, S. (2021) · Cardiovascular Diabetology · doi:10.1186/s12933-021-01322-6 · Cited by 53
Nakao, M., Shimizu, I., Katsuumi, G., Yoshida, Y., Suda, M., Hayashi, Y., Ikegami, R., Hsiao, Y., Okuda, S., Soga, T., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-97787-2 · Cited by 51
Ulk1/FUNDC1 Prevents Nerve Cells from Hypoxia-Induced Apoptosis by Promoting Cell Autophagy
Wang, L., Wang, P., Dong, H., Wang, S., Chu, H., Yan, W., & Zhang, X. (2018) · Neurochemical Research · doi:10.1007/s11064-018-2568-x · Cited by 49
SOX9 is required for kidney fibrosis and activates NAV3 to drive renal myofibroblast function
Raza, S., Jokl, E. J., Pritchett, J. P., Martin, K., Su, K., Simpson, K., Birchall, L., Mullan, A. F., Athwal, V. S., Doherty, D. T., et al. (2021) · Science Signaling · doi:10.1126/scisignal.abb4282 · Cited by 49
Abe, H., Tanada, Y., Omiya, S., Podaru, M., Murakawa, T., Ito, J., Shah, A. M., Conway, S. J., Ono, M., & Otsu, K. (2021) · Science Signaling · doi:10.1126/scisignal.abe4932 · Cited by 48
Yurista, S. R., Silljé, H. H. W., Rienstra, M., de Boer, R. A., & Westenbrink, B. D. (2020) · Cardiovascular Diabetology · doi:10.1186/s12933-019-0984-0 · Cited by 47
Mitochondrial Division Inhibitor 1 Attenuates Mitophagy in a Rat Model of Acute Lung Injury
Luo, X., Liu, R., Zhang, Z., Chen, Z., He, J., & Liu, Y. (2019) · BioMed Research International · doi:10.1155/2019/2193706 · Cited by 44
Self-citationSGLT2 inhibitors in people with and without T2DM
Khunti, K. (2020) · Nature Reviews Endocrinology · doi:10.1038/s41574-020-00453-2 · Cited by 43
Tian, G., Yu, Y., Deng, H., Liu, Y., Shi, X., & Yu, B. (2021) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.13470 · Cited by 41
Huang, S., Li, Z., Wu, Z., Liu, C., Yu, M., Wen, M., Zhang, L., & Wang, X. (2021) · Science Signaling · doi:10.1126/scisignal.abc7931 · Cited by 41
Self-citationGe, H., Lin, W., Lou, Z., Chen, R., Shi, H., Zhao, Q., & Lin, Z. (2021) · Microvascular Research · doi:10.1016/j.mvr.2021.104302 · Cited by 39
Feno, S., Munari, F., Reane, D. V., Gissi, R., Hoang, D.-H., Castegna, A., Chazaud, B., Viola, A., Rizzuto, R., & Raffaello, A. (2021) · Science Signaling · doi:10.1126/scisignal.abf3838 · Cited by 35
Song, Y., Xing, H., He, Y., Zhang, Z., Shi, G., Su, W., Liu, Y., Harrington, E. O., Sellke, F. W., & Feng, J. (2021) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2021.06.029 · Cited by 34
Kakavand, H., Aghakouchakzadeh, M., Coons, J. C., & Talasaz, A. H. (2021) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000980 · Cited by 33
STEMI care 2021: Addressing the knowledge gaps
Yıldız, M., Wade, S. R., & Henry, T. D. (2021) · American Heart Journal Plus Cardiology Research and Practice · doi:10.1016/j.ahjo.2021.100044 · Cited by 33
Marongiu, L., Mingozzi, F., Cigni, C., Marzi, R., Gioia, M. D., Garrè, M., Parazzoli, D., Sironi, L., Collini, M., Sakaguchi, R., et al. (2021) · Science Signaling · doi:10.1126/scisignal.aaz2120 · Cited by 31
Wu, D., Ji, H., Du, W., Ren, L., & Qian, G. (2022) · Bioengineered · doi:10.1080/21655979.2022.2027065 · Cited by 30
Canet, F., Iannantuoni, F., Marañón, A., Díaz-Pozo, P., López‐Domènech, S., Vezza, T., Navarro, B., Solá, E., Falcón, R., Bañuls, C., et al. (2021) · Antioxidants · doi:10.3390/antiox10081228 · Cited by 29
Mao, D. Y., Kleinjan, M. L., Jilishitz, I., et al. (2021) · Science Signaling · doi:10.1126/scisignal.abc0425 · Cited by 27
Chen, Y., Liu, C., Zhou, P., Li, J., Zhao, X., Wang, Y., Chen, R., Song, L., Zhao, H., & Yan, H. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/6699516 · Cited by 25
Ribeiro, L. F., Catarino, T., de Carvalho, M. L., Cortes, L., Santos, S. D., Opazo, P., Ribeiro, L. R., Oliveiros, B., Choquet, D., Esteban, J. A., et al. (2021) · Science Signaling · doi:10.1126/scisignal.abb1953 · Cited by 25
Drp-1 as Potential Therapeutic Target for Lipopolysaccharide-Induced Vascular Hyperpermeability
Luo, X., Cai, S., Li, Y., Li, G., Cao, Y., Ai, C., Gao, Y., & Li, T. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/5820245 · Cited by 20
Ernst, O., Sun, J., Lin, B., Banoth, B., Dorrington, M. G., Liang, J. J., Schwarz, B. H., Stromberg, K. A., Katz, S., Vayttaden, S. J., et al. (2021) · Science Signaling · doi:10.1126/scisignal.abe0387 · Cited by 20
Cited by
Luna-Marco, C., Iannantuoni, F., Hermo-Argibay, A., Devos, D., Salazar, J. D., Víctor, V. M., & Rovira-Llopis, S. (2024) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2024.01.015 · Cited by 114
Salvatore, T., Galiero, R., Caturano, A., Vetrano, E., Loffredo, G., Rinaldi, L., Catalini, C., Gjeloshi, K., Albanese, G., Di Martino, A., et al. (2022) · Biomedicines · doi:10.3390/biomedicines10092274 · Cited by 98
“likely elucidated the pathways by which SGLT2 inhibition provides a cardioprotective effect against I/R injury and could justify the infarct-sparing effect observed in hearts from diabetic and nondiabetic rats treated for 4 weeks with canagliflozin [285,290].”
BackgroundMethod
Metadata
- Authors
- Cai, C., Guo, Z., Chang, X., Li, Z., Wu, F., He, J., Cao, T., Wang, K., Shi, N., Zhou, H., Toan, S., Muid, D., & Tan, Y.
- Venue
- Redox Biology
- Publisher
- Elsevier BV
- Published
- 2022-06
- Volume
- 52
- Pages
- 102288
- ISSN
- 2213-2317 (ISSN-L)
- OpenAlex
- W4220938112
- Cited by
- 261
- References
- 71
- FWCI
- 27.48
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.